Dr. Samy Suissa
October 2016Research at the Lady Davis Institute

Mandate renewed for Canada-wide drug safety consortium based at the LDI

A renewed five-year mandate has been granted to a national consortium on prescription drug safety that is headquartered in the Lady Davis Institute at the JGH.

READ MORE →
Dr. Reem el Sherif presented her research about online consumer health information at the annual meeting of the North American Primary Care Research Group.
October 2016Research at the Lady Davis Institute

Looking for healthcare info online? Go ahead, but be careful

If you think you’re sick, based on something you’ve read online, Dr. Reem el Sherif has a word to share with you: cyberchondria.

READ MORE →
Dr. Yves Longtin
October 2016Research at the Lady Davis Institute

Broader screening helps reduce C. difficile infection

The rate of C. difficile infection among hospitalized patients drops dramatically when all patients are tested for the bacteria before being admitted to hospital, says a clinical study headed by a JGH physician and researcher.

READ MORE →
Dr. Arezu Jahani-Asl
October 2016Research at the Lady Davis Institute

Key mechanism identified in deadly brain tumours

A key to understanding the formation of the most aggressive type of brain tumour in adults has been revealed at the JGH.

READ MORE →
October 2016Research at the Lady Davis Institute

Trying to understand the higher likelihood of depression in girls

It’s a scientific conundrum: Twice as many girls as boys develop anxiety and depressive disorders by the time they reach early adolescence.

READ MORE →
Among those at the JGH Department of Psychiatry’s 11th annual Research Day were (rear, from left) Dr. David Dunkley (organizer of the event), Dr. Phyllis Zelkowitz (founder of the event), psychiatry researcher and presenter Dr. Catherine Fichten, discussant Dr. Ashok Malla, and (front, from left) presenter Dr. Michael Bond, Dr. Karl Looper (JGH Chief of Psychiatry), Anita David (representing the Gustav Levinschi Foundation which supports the event), and presenter Dr. Jazwant Guzder (Director of the JGH Centre for Child Development and Mental Health).
October 2016Research at the Lady Davis Institute

Focus on youth at 11th annual Psychiatry Research Day

Youths at risk were the focus of discussions among healthcare professionals in the mental health field at the JGH Department of Psychiatry’s 11th annual Research Day in April.

READ MORE →
Among the participants who explored Alzheimer’s disease at the Science Day at the JGH were (standing, from left) Dr. Stephen Cunane (University of Sherbrooke), Dr. Louis Collins (McGill University), Dr. Serge Gauthier (McGill and the Douglas Mental Health University Insitute), Dr. Naguib Mechawar (McGill and the Douglas), Dr. Frédéric Calon (University of Laval), Dr. Howard Chertkow (Lady Davis Institute and McGill), Dr. Remi Quirion (Chief Scientist of Quebec), and (seated, from left) Dr. Nicole Leclerc (University of Montreal and the University of Montreal Hospital Centre), Dr. Pierette Gaudreau (University of Montreal and the the University of Montreal Hospital Centre), Dr. Andréa LeBlanc (LDI and McGill), and Dr. Sylvie Belleville (University of Montreal and the Montreal University Institute of Geriatrics).
October 2016Research at the Lady Davis Institute

Mobilized against Alzheimer’s disease

Researchers in the field of Alzheimer’s disease gathered at the JGH in May to share ideas and insights at the annual Science Day of the Consortium for the Early Identification of Alzheimer’s Disease – Quebec.

READ MORE →
Dr. Mark Eisenberg
April 2016Research at the Lady Davis Institute

Drug shows promise for those trying to quit smoking after a heart attack

Nearly half of the heavy smokers who were admitted to hospital after a heart attack had successfully quit smoking six months after being given the drug varenicline.

READ MORE →
Dr. H. Uri Saragovi
April 2016Research at the Lady Davis Institute

New hope for dry eye sufferers

People who suffer from chronic dry eye disease have new hope for relief, with the development of a promising treatment.

READ MORE →
Dr. Lawrence Rosenberg
April 2016Research at the Lady Davis Institute

Landmark clinical trial under way for type 1 diabetes treatment

Patients with long-standing type 1 diabetes are undergoing a clinical trial for a therapeutic approach that combines an agent for stimulating the growth of insulin-secreting cells in the pancreas, along with a drug to prevent the autoimmune system from rejecting the newly formed cells.

READ MORE →